BioMarin Pharmaceuticals
BMRN
BMRN
422 hedge funds and large institutions have $15.4B invested in BioMarin Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 66 funds opening new positions, 175 increasing their positions, 120 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2% more call options, than puts
Call options by funds: $127M | Put options by funds: $124M
0% more funds holding in top 10
Funds holding in top 10: 13 → 13 (0)
Holders
422
Holding in Top 10
13
Calls
$127M
Puts
$124M
Top Buyers
| 1 | +$404M | |
| 2 | +$75.4M | |
| 3 | +$72.3M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$64.9M |
| 5 |
Jennison Associates
New York
|
+$60.2M |
Top Sellers
| 1 | -$91.9M | |
| 2 | -$86.8M | |
| 3 | -$64.5M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$63M |
| 5 |
HM
HealthCor Management
New York
|
-$58.4M |